跳至主要内容
临床试验/CTRI/2022/09/045629
CTRI/2022/09/045629尚未招募2 期

Management of Diabetic Nephropathy (Stage 1 and 2) by using Ayurveda Medications ââ?¬â??An Open Labelled Single Arm Study

All India Institue Of Ayurveda0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Diabetic patients having controlled blood glucose level upto
  • FBS:130mg/dl
  • PPBS:180mg/dl. (American Diabetes Association)
  • c) Hypertensive patients BP < 140/90 mm of Hg
  • d) Urinary albumin between 30-300mg in 24 Hr. urine sample
  • e) G.F.R. between 60-120ml/min/1.73m2

排除标准

  • Uncontrolled diabetic patients if blood glucose level more than-
  • FBS: 130 mg/dl
  • PPBS:180 mg/dl
  • b) Uncontrolled Hypertensive patients BP ââ?°Â¥140/90 mm of Hg.
  • c) Microalbuminuria originating due to other diseases
  • d) Patients with other severe complications of Diabetes Mellitus.
  • e) Serum creatinine more than 2.5 mg.
  • f) Albumin >300mg/day.
  • g) G.F.R. <60 ml/min.
  • h) Any other serious systemic illness.

研究者

发起方
All India Institue Of Ayurveda

相似试验